JP6158219B2 - 皮膚の色素沈着を治療するための組成物 - Google Patents

皮膚の色素沈着を治療するための組成物 Download PDF

Info

Publication number
JP6158219B2
JP6158219B2 JP2014548058A JP2014548058A JP6158219B2 JP 6158219 B2 JP6158219 B2 JP 6158219B2 JP 2014548058 A JP2014548058 A JP 2014548058A JP 2014548058 A JP2014548058 A JP 2014548058A JP 6158219 B2 JP6158219 B2 JP 6158219B2
Authority
JP
Japan
Prior art keywords
extract
bilirubin
composition
plant
strelitzia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014548058A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015511211A5 (cg-RX-API-DMAC10.html
JP2015511211A (ja
Inventor
グルーバー、ジェームズ・ビンセント
ルートビッヒ、フィリップ・レデット
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Publication of JP2015511211A publication Critical patent/JP2015511211A/ja
Publication of JP2015511211A5 publication Critical patent/JP2015511211A5/ja
Application granted granted Critical
Publication of JP6158219B2 publication Critical patent/JP6158219B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/728—Bilirubin; including biliverdin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/146666—Bile pigment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
JP2014548058A 2011-12-22 2012-12-21 皮膚の色素沈着を治療するための組成物 Expired - Fee Related JP6158219B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161579178P 2011-12-22 2011-12-22
US61/579,178 2011-12-22
PCT/EP2012/076589 WO2013092973A2 (en) 2011-12-22 2012-12-21 Composition for treating skin pigmentation

Publications (3)

Publication Number Publication Date
JP2015511211A JP2015511211A (ja) 2015-04-16
JP2015511211A5 JP2015511211A5 (cg-RX-API-DMAC10.html) 2016-02-12
JP6158219B2 true JP6158219B2 (ja) 2017-07-05

Family

ID=47458981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014548058A Expired - Fee Related JP6158219B2 (ja) 2011-12-22 2012-12-21 皮膚の色素沈着を治療するための組成物

Country Status (5)

Country Link
US (2) US20130164234A1 (cg-RX-API-DMAC10.html)
EP (1) EP2822660B1 (cg-RX-API-DMAC10.html)
JP (1) JP6158219B2 (cg-RX-API-DMAC10.html)
KR (1) KR20140107547A (cg-RX-API-DMAC10.html)
WO (1) WO2013092973A2 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170296458A1 (en) * 2016-04-14 2017-10-19 The Procter & Gamble Company Cosmetic composition
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
US10874600B2 (en) * 2018-06-18 2020-12-29 The Procter & Gamble Company Method for degrading bilirubin in skin
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
US11786451B2 (en) 2019-06-28 2023-10-17 The Procter & Gamble Company Skin care composition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
KR102300141B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리 패션 스타일 춘추 잠바
KR102300135B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리 패션 스타일 신발
CN114588094A (zh) * 2022-02-23 2022-06-07 郭进平 一种具有祛痘印功效的护肤组合物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2239345A (en) 1939-06-19 1941-04-22 Inst Divi Themae Foundation Proliferation stimulants and process of making same
US3067103A (en) * 1960-07-22 1962-12-04 James Y P Chen Healing-enhancing preparations comprising gardenia florida seed extract and pharmaceutically acceptable carrier formulations
GB1541463A (en) 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4960764A (en) 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
CH679012A5 (cg-RX-API-DMAC10.html) * 1990-11-27 1991-12-13 Magdalena Mrak
EP0614353A1 (en) 1991-11-25 1994-09-14 Richardson-Vicks, Inc. Compositions for regulating skin wrinkles and/or skin atrophy
US5681852A (en) 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US6607735B2 (en) * 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
US20030198682A1 (en) 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
US20070122492A1 (en) * 2004-11-18 2007-05-31 Stephen Behr Plant extracts and dermatological uses thereof
US7288263B2 (en) 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
US9657257B2 (en) * 2007-05-10 2017-05-23 Kimberly-Clark Worldwide, Inc. Colorant neutralizer
FR2918885B1 (fr) * 2007-07-17 2009-08-28 Oreal Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
FR2930557B1 (fr) * 2008-04-29 2013-08-30 Lvmh Rech Matieres colorantes d'origine vegetale et leur utilisation pour colorer des compositions, en particulier des compositions cosmetiques
WO2010018526A2 (en) * 2008-08-11 2010-02-18 S.S. Arbel Holdings (1992) Ltd Composition for treatment of the skin
US8178106B2 (en) * 2009-03-30 2012-05-15 Mary Kay Inc. Topical skin care formulations
US20090263435A1 (en) 2009-05-07 2009-10-22 L'oreal S.A. Compositions and methods for minimizing and/or reducing the appearance of defects around eyes
FR2954698B1 (fr) * 2009-12-29 2015-10-23 Lvmh Rech Extrait de la plante ravenala madagascariensis et utilisation comme agent cosmetique hydratant
US20120045405A1 (en) * 2010-08-18 2012-02-23 Gilman Miles E Under eye cream
KR102121704B1 (ko) * 2011-04-21 2020-06-29 마리 케이 인코포레이티드 식물 추출물을 포함하는 국소 스킨 케어 제형

Also Published As

Publication number Publication date
KR20140107547A (ko) 2014-09-04
EP2822660A2 (en) 2015-01-14
US20130164234A1 (en) 2013-06-27
WO2013092973A3 (en) 2014-12-31
US20150190337A1 (en) 2015-07-09
WO2013092973A2 (en) 2013-06-27
EP2822660B1 (en) 2017-01-18
JP2015511211A (ja) 2015-04-16
US10034830B2 (en) 2018-07-31

Similar Documents

Publication Publication Date Title
JP2015511211A (ja) 皮膚の色素沈着を治療するための組成物
CN103479694B (zh) 含有人参的花或人参的种子提取物的皮肤外用剂组合物
JP7758679B2 (ja) ラベンダーの水性抽出物を得る方法、そのような抽出物を含む組成物、およびその化粧的使用
JP6387219B2 (ja) タンゲレチン及びｅｇｃｇを含有する皮膚外用剤組成物
CN106038342A (zh) 一种新型防晒、抗氧化、美白化妆品组合物及其制备方法
CN102665709A (zh) 皮肤净化复合物,所述复合物的用途,包含所述复合物的化妆品或药物组合物及其使用方法
JP2001122757A (ja) 活性酸素消去剤、抗酸化剤および化粧料
CN111450003A (zh) 含黄金香柳提取物的抗初老亮颜营养物及其制备方法和精华液、黄金香柳提取物的提取方法
CN107530273A (zh) 含有缬草提取物的组合物
US10363212B2 (en) Aesculus hippocastanum extract
KR20190137328A (ko) 병아리꽃나무 추출물을 포함하는 항노화용 피부외용제 조성물
JP2009209063A (ja) 皮膚外用剤または皮膚化粧料
JP2023138224A (ja) 抗酸化および美白効能に優れた化粧料用組成物
JP3660833B2 (ja) 血行促進剤
EP2198847A2 (en) Compositions comprising self-tanning agents and plant extracts
JP3295665B2 (ja) 美白用皮膚外用剤
US20130317116A1 (en) External skin preparation
EP2198848A2 (en) Compositions comprising self-tanning agents and sugar amines
KR101957411B1 (ko) 생약 추출물 함포 펙틴 마이크로캡슐을 포함하는 피부 개선용 화장료 조성물
FR3008890B1 (fr) Extrait de chene, composition comprenant ledit extrait et utilisations notamment cosmetiques
JP2003277280A (ja) 一重項酸素消去剤、並びに老化防止用皮膚外用剤
KR100702176B1 (ko) 저 자극성 화장료 조성물
JPH0249709A (ja) ログウッド抽出物含有メラニン生成抑制剤
KR102628074B1 (ko) 꿩의밥 추출물을 포함하는 항노화용 피부외용제 조성물
EP4724036A1 (en) Oak bark extract and cosmetic uses thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151218

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20151218

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20160822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160822

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161011

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170310

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170509

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170607

R150 Certificate of patent or registration of utility model

Ref document number: 6158219

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees